BioSig Technologies ( (BSGM) ) has released a notification of late filing.
BioSig Technologies, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to time constraints faced by the company’s management in compiling and reviewing the necessary financial information, which made timely filing impractical without incurring undue hardship and expense. The company expects to file the report no later than the fifteenth calendar day following the prescribed due date. Financially, BioSig Technologies anticipates reporting a significant decrease in research and development expenses for 2024 compared to the previous year, with revenue slightly increasing from $18,000 to $40,000. Investors are advised that these figures are preliminary and subject to change. The company remains committed to compliance, as evidenced by the notification signed by CEO Anthony Amato.
More about BioSig Technologies
YTD Price Performance: -57.86%
Average Trading Volume: 293,572
Technical Sentiment Signal: Strong Buy
Current Market Cap: $13.59M
See more insights into BSGM stock on TipRanks’ Stock Analysis page.